Lucid Diagnostics (LUCD) Net Equity Issued and Repurchased (2023 - 2026)
Lucid Diagnostics' (LUCD) quarterly Net Equity Issued and Repurchased came in at $1.8 million in Q1 2024, up 533.8% YoY from $284000.0 in Q2 2023, and up 18.73% on a QoQ basis from $1.5 million in Q3 2023.
Lucid Diagnostics (LUCD) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $1.8 million in Q1 2024.
- Quarterly Net Equity Issued and Repurchased rose 533.8% year-over-year to $1.8 million in Q1 2024, while the trailing twelve-month figure through Mar 2026 was $1.8 million (changed 0.0% YoY) and the FY2025 annual result came in at $274000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased climbed to $1.8 million in Q1 2024, from $1.5 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $1.8 million in Q1 2024 to a low of $284000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Lucid Diagnostics | 175.80 Mn | 142.40 Mn | 55,000.00 | 11.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.55 Mn |
| Jun 30, 2026 | 11.55 Mn |
| Mar 31, 2026 | 5.30 Mn |
| Mar 31, 2026 | 5.30 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 14.93 Mn |
| Mar 31, 2025 | 14.93 Mn |
| Mar 31, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.80 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 284,000.00 |
| Mar 31, 2023 | 284,000.00 |